Nurix Therapeutics Inc
(NRIX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 11/30
(Values in U.S. thousands)
| 11-2025 | 11-2024 | 11-2023 | 11-2022 | 11-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 246,960 | 109,997 | 54,627 | 64,474 | 80,506 |
| Marketable Securities | 345,981 | 499,586 | 233,281 | 244,667 | 215,214 |
| Receivables | N/A | N/A | N/A | N/A | 6,204 |
| TOTAL | $606,819 | $619,387 | $295,503 | $318,449 | $311,118 |
| Non-Current Assets | |||||
| PPE Net | 22,490 | 17,757 | 16,808 | 17,163 | 11,340 |
| Investments And Advances | 0 | 0 | 7,421 | 63,879 | 137,189 |
| Other Non-Current Assets | 58,826 | 32,199 | 35,866 | 17,268 | 17,124 |
| TOTAL | $81,316 | $49,956 | $60,095 | $98,310 | $165,653 |
| Total Assets | $688,135 | $669,343 | $355,598 | $416,759 | $476,771 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 11,215 | 11,482 | 6,401 | 5,064 | 6,650 |
| Accrued Expenses | 54,852 | 37,994 | 24,970 | 22,428 | 14,549 |
| TOTAL | $86,471 | $95,854 | $86,958 | $70,655 | $66,258 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 17,580 | 38,364 | 48,098 | 37,633 | 41,212 |
| Other Non-Current Liabilities | 52,906 | 20,289 | 23,125 | 6,434 | 9,189 |
| TOTAL | $62,917 | $46,496 | $68,147 | $42,408 | $68,211 |
| Total Liabilities | $149,388 | $142,350 | $155,105 | $113,063 | $134,469 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 102,843 | 75,887 | 48,894 | 47,273 | 44,738 |
| Common Shares | 102 | 76 | 49 | 47 | 45 |
| Retained earnings | -1,003,226 | -738,769 | -545,200 | -401,252 | -220,892 |
| Other shareholders' equity | 105 | 150 | -655 | -4,319 | -608 |
| TOTAL | $538,747 | $526,993 | $200,493 | $303,696 | $342,302 |
| Total Liabilities And Equity | $688,135 | $669,343 | $355,598 | $416,759 | $476,771 |